Literature DB >> 16144820

Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats.

Dóra Zelena1, Ludmila Filaretova, Zsuzsa Mergl, István Barna, Zsuzsanna E Tóth, Gábor B Makara.   

Abstract

Diabetes mellitus (DM), as chronic stress activates the hypothalamo-pituitary-adrenocortical axis. We examined whether arginine vasopressin (AVP) and the hypothalamic paraventricular nucleus (PVN) participate in DM-induced chronic stress symptoms. AVP-deficient Brattleboro or PVN-lesioned Wistar rats were used with heterozygous or sham-operated controls. The rats were studied 2 wk after a single injection of streptozotocin. The appearance of DM (enhanced water consumption and blood glucose elevation) and the chronic stress-like somatic changes (body weight decrease, thymus involution, adrenal gland hypertrophy) were not influenced by the lack of AVP. By contrast, PVN lesion significantly attenuated DM-induced thymus involution and adrenal gland hypertrophy as well as the increase in water consumption. The corticotropin-releasing hormone mRNA in PVN was diminished by DM and elevated by the lack of AVP without interaction. DM elevated the proopiomelanocortin (POMC) mRNA in the anterior lobe of the pituitary. The lack of AVP had no effect, whereas lesioning the PVN significantly diminished the elevation. The elevated basal corticosterone plasma levels detectable in DM were influenced neither by the lack of AVP nor by lesioning the PVN. Thus the lack of AVP had no influence on DM-induced chronic stress symptoms, but lesioning the PVN attenuated part of them. However, the lack of elevation in POMC mRNA after PVN lesion, together with the maintained corticosterone elevation, suggests that direct adrenal gland activation occurs in untreated DM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16144820     DOI: 10.1152/ajpendo.00118.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

1.  Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring.

Authors:  Snigdha Mukerjee; Yun Zhu; Andrea Zsombok; Franck Mauvais-Jarvis; Jinying Zhao; Eric Lazartigues
Journal:  Cell Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.046

2.  The vasopressin-deficient Brattleboro rat: lessons for the hypothalamo-pituitary-adrenal axis regulation.

Authors:  Gábor B Makara; János Varga; István Barna; Ottó Pintér; Barbara Klausz; Dóra Zelena
Journal:  Cell Mol Neurobiol       Date:  2012-04-19       Impact factor: 5.046

3.  Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Yo Na Kim; Il Yong Kim; Son-Il Pak; In Se Lee; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

4.  The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats.

Authors:  Lilla Lenart; Judit Hodrea; Adam Hosszu; Sandor Koszegi; Dora Zelena; Dora Balogh; Edgar Szkibinszkij; Apor Veres-Szekely; Laszlo Wagner; Adam Vannay; Attila J Szabo; Andrea Fekete
Journal:  Psychopharmacology (Berl)       Date:  2016-01-26       Impact factor: 4.530

5.  Arginine vasopressin (AVP) expressional changes in the hypothalamic paraventricular and supraoptic nuclei of stroke-prone spontaneously hypertensive rats.

Authors:  Sun Shin Yi; Hyun-Jin Kim; Seon-Gil Do; Yoon-Bok Lee; Hee Jin Ahn; In Koo Hwang; Yeo Sung Yoon
Journal:  Anat Cell Biol       Date:  2012-06-30

6.  Bolus Injection of Liraglutide Raises Plasma Glucose in Normal Rats by Activating Glucagon-like Peptide 1 Receptor in the Brain.

Authors:  Chia-Chen Hsu; Juei-Tang Cheng; Ping Hao Hsu; Yingxiao Li; Kai-Chun Cheng
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-21

7.  Stress responsiveness of the hypothalamic-pituitary-adrenal axis: age-related features of the vasopressinergic regulation.

Authors:  Nadezhda D Goncharova
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-12       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.